Stockscreener 앱 받기
32.60
1.27%
0.41
시간 외 거래:
32.73
0.13
+0.40%
전일 마감가:
$32.19
열려 있는:
$32.09
하루 거래량:
2.54M
Relative Volume:
0.56
시가총액:
$14.00B
수익:
$2.27B
순이익/손실:
$1.15B
주가수익비율:
12.78
EPS:
2.55
순현금흐름:
$2.80B
1주 성능:
+4.45%
1개월 성능:
-1.27%
6개월 성능:
+16.22%
1년 성능:
+18.07%
1일 변동 폭
$32.09
$32.66
1주일 범위
$30.96
$32.66
52주 변동 폭
$24.05
$34.20
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
32.60 | 14.00B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Treasurer of the State of North Carolina Has $4.39 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
Royalty Pharma plc to Announce Q1 2025 Financial Results on May 8, 2025 - Nasdaq
Legal & General Group Plc Has $67.19 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management N.V. Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Portolan Capital Management LLC Acquires 173,721 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Aviva PLC Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
CenterBook Partners LP Sells 113,525 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
APG Asset Management US Inc. Buys Shares of 7,872 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Fmr LLC - MarketBeat
Franklin Resources Inc. Has $13.76 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
ADAR1 Capital Management LLC Sells 1,046,703 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
JPMorgan Chase & Co. Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma modifies acquisition agreement By Investing.com - Investing.com South Africa
Royalty Pharma modifies acquisition agreement - Investing.com
ExodusPoint Capital Management LP Invests $3.66 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Prudential PLC - MarketBeat
Headlands Technologies LLC Has $115,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Geode Capital Management LLC Grows Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know - Yahoo Finance
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Position Cut by Rhenman & Partners Asset Management AB - MarketBeat
Integrated Quantitative Investments LLC Buys New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Enters Oversold Territory - Nasdaq
Russell Investments Group Ltd. Purchases 449,551 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Arrowstreet Capital Limited Partnership Sells 720,342 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Sei Investments Co. - MarketBeat
Royalty Pharma Appoints Vlad Coric to Board of Directors - citybiz
Royalty Pharma expands board with Biohaven CEO appointment By Investing.com - Investing.com South Africa
Royalty Pharma expands board with Biohaven CEO appointment - Investing.com Australia
Royalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of Directors - The Manila Times
Biotech Leader Behind $13B Pfizer-Biohaven Deal Takes Strategic Role at Royalty Pharma - Stock Titan
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Alliancebernstein L.P. - MarketBeat
California Public Employees Retirement System Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Allstate Corp Takes $299,000 Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Pictet Asset Management Holding SA Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Trexquant Investment LP Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Korea Investment CORP Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.49%
자본화:
|
볼륨(24시간):